⌘K

Login Start Free

Home/Filings/4/0001179110-15-008722

4//SEC Filing

OSIRIS THERAPEUTICS, INC. 4

Accession 0001179110-15-008722

CIK 0001360886operating

View on SEC.gov Company Profile

Filed

May 28, 8:00 PM ET

Accepted

May 29, 4:30 PM ET

Size

14.4 KB

Accession

0001179110-15-008722

Insider Transaction Report

Form 4

Period: 2015-05-27

OSIRIS THERAPEUTICS, INC.OSIR

JACOBY PHILIP R JR

Vice President of Finance

Transactions

Exercise/Conversion
Common Stock
2015-05-27$6.46/sh+3,751$24,231→ 27,640 total
Exercise/Conversion
Common Stock
2015-05-27$7.74/sh+11,389$88,151→ 23,889 total
Exercise/Conversion
Common Stock
2015-05-27$7.13/sh+4,860$34,652→ 32,500 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2015-05-27$7.74/sh−11,389$88,151→ 67,792 total
Exercise: $7.74From: 2013-03-12Exp: 2020-03-12→ Common Stock (11,389 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2015-05-27$7.13/sh−4,860$34,652→ 59,181 total
Exercise: $7.13From: 2013-02-14Exp: 2021-02-14→ Common Stock (4,860 underlying)
Sale
Common Stock
2015-05-27$18.55/sh−20,000$371,080→ 12,500 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2015-05-27$6.46/sh−3,751$24,231→ 64,041 total
Exercise: $6.46From: 2013-05-27Exp: 2020-05-27→ Common Stock (3,751 underlying)

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

OSIRIS THERAPEUTICS, INC.

CIK 0001360886

Entity typeoperating

IncorporatedMD

Related Parties

1

filerCIK 0001360886

Filing Metadata

Form type: 4
Filed: May 28, 8:00 PM ET
Accepted: May 29, 4:30 PM ET
Size: 14.4 KB

View on SEC.gov